Equifax 2011 Annual Report Download - page 61

Download and view the complete annual report

Please find page 61 of the 2011 Equifax annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

The following table summarizes changes in outstanding stock options during the twelve months ended December 31, 2011, as well as stock
options that are vested and expected to vest and stock options exercisable at December 31, 2011:
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Term
Aggregate
Intrinsic
Value
(in thousands) (in years) (in millions)
Outstanding at December 31, 2010 6,526 $30.63
Granted (all at market price) 1,298 $32.94
Exercised (947) $25.02
Forfeited and cancelled (162) $32.99
Outstanding at December 31, 2011 6,715 $31.82 6.3 $47.9
Vested and expected to vest at December 31, 2011 6,472 $31.86 6.2 $46.0
Exercisable at December 31, 2011 4,289 $31.71 4.8 $31.6
The aggregate intrinsic value amounts in the table above represent
the difference between the closing price of Equifax’s common stock
on December 31, 2011 and the exercise price, multiplied by the
number of in-the-money stock options as of the same date. This
represents the value that would have been received by the stock
option holders if they had all exercised their stock options on
December 31, 2011. In future periods, this amount will change
depending on fluctuations in Equifax’s stock price. The total intrinsic
value of stock options exercised during the twelve months ended
December 31, 2011, 2010 and 2009, was $9.9 million, $14.7 million
and $5.1 million, respectively. At December 31, 2011, our total
unrecognized compensation cost related to stock options was
$7.7 million with a weighted-average recognition period of 1.5 years.
The following table summarizes changes in outstanding options and the related weighted-average exercise price per share for the twelve
months ended December 31, 2010 and 2009:
December 31,
2010 2009
Shares
Weighted-
Average Price Shares
Weighted-
Average Price
(Shares in thousands) (Shares in thousands)
Outstanding at the beginning of the year 6,845 $28.68 6,422 $27.84
Granted (all at market price) 1,216 $32.02 1,198 $28.49
Exercised (1,358) $21.58 (589) $17.35
Forfeited and cancelled (177) $34.04 (186) $33.70
Outstanding at the end of the year 6,526 $30.63 6,845 $28.68
Exercisable at end of year 4,248 $30.28 4,780 $27.21
EQUIFAX 2011 ANNUAL REPORT 59